GLP-1 Weight-Loss Drugs Create New Demand Reality for U.S. Potato Growers

from Where Landowners Get Their News · host American Farmland Owner with Dave Price

The rapid adoption of GLP‑1 weight‑loss drugs like Ozempic and Wegovy is reducing overall food consumption, creating new demand challenges for U.S. potato growers. Jamey Higham, president and CEO of the Idaho Potato Commission, says the shift could deepen potato oversupply and force growers to better align production and marketing with changing eating habits.

Episode metadata supplied by the publisher feed · Published May 1, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

GLP-1 Weight-Loss Drugs Create New Demand Reality for U.S. Potato Growers

0:00 29:39

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Where Landowners Get Their News?

This episode is 29 minutes long.

When was this Where Landowners Get Their News episode published?

This episode was published on May 1, 2026.

Can I download this Where Landowners Get Their News episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!